An Israeli pharma champion sickens | The Economist
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
Teva relocates headquarters in Israel
Israel's Teva halts testing alternative use for migraine drug - Business - Haaretz.com
Teva Israel steps into the ring to begin distributing medical cannabis - The Jerusalem Post
Fallout from Teva plant closings, global layoffs continues in Israel | Fierce Pharma
What's 'down' with Teva? - Israel News - The Jerusalem Post
Teva to be Sole Distributor of COVID-19 Vaccines in Israel | The Jewish Press - JewishPress.com | Hana Levi Julian | 21 Kislev 5781 – December 6, 2020 | JewishPress.com
Teva moves to cut hundreds of manufacturing jobs in Israel | Fierce Pharma
Israel's Teva donating potential COVID-19 treatment to US hospitals - ISRAEL21c
Teva Pharmaceuticals - Wikipedia
Jerusalem, Israel. 21st Oct, 2019. The Teva Pharmaceutical logo is seen in English and Hebrew at their tablet production plant in Jerusalem, on Monday, October 21, 2019. The Israeli drug manufacturer Teva's
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Teva's Israeli Plant Receives FDA Stamp of Approval for Migraine Drug Manufacturing | Ctech
Allergan sells generic drug unit to Israel's Teva for $40.5 billion - Los Angeles Times
Former Teva officials said to return $50m over fines paid by drugmaker | The Times of Israel
Pharmaceutical giant Teva to lay off employees at Israel branches - Israel News - The Jerusalem Post
Israeli drug giant Teva to move offices to Tel Aviv - Israel News - The Jerusalem Post
Teva shares tumble as company faces price-fixing lawsuit - Israel News - The Jerusalem Post
Teva, Technion To Collaborate On Cancer, Neurobiology Research
Israeli drugmaker Teva to cut quarter of global work force (Update)
Teva to cut 14,000 jobs | Business | Chemistry World
Teva shares rally as FDA approves troubled drugmaker's migraine treatment | The Times of Israel
Can Israel find a cure for ailing drug giant Teva? – Mishpacha Magazine
Teva Israel enters medical cannabis market with new partnership | Reuters
The Unlikely Source of a Healthtech Revolution - Bloomberg